av/heat-biologics--big.svg

AMEX:HTBX

Heat Biologics, Inc.

  • Stock

USD

Last Close

2.37

03/05 04:00

Market Cap

61.07M

Beta: 0.30

Volume Today

43.61K

Avg: 155.10K

PE Ratio

−1.69

PFCF: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
net income
-11.79M
-
-20.30M
72.15%
-12.57M
38.04%
-11.84M
5.82%
-15.73M
32.87%
-20.02M
27.23%
-26.05M
30.13%
-35.40M
35.90%
depreciation and amortization
66.89K
-
116K
73.41%
132.08K
13.86%
134.08K
1.52%
237.32K
76.99%
232.51K
2.03%
333.15K
43.29%
deferred income tax
stock based compensation
1.07M
-
1.57M
47.59%
582.63K
62.98%
689.13K
18.28%
788.66K
14.44%
3.27M
314.62%
6.38M
95.04%
change in working capital
1.06M
-
1.74M
63.96%
-1.52M
186.98%
5.06M
433.87%
-6.64M
231.31%
2.65M
139.86%
-4.70M
277.42%
-14.68M
212.47%
accounts receivables
-127.44K
-
67.77K
153.18%
-14.09K
120.80%
-6.47K
54.08%
-140.56K
2,071.80%
inventory
-9.38K
-
-719.15K
7,564.37%
176.81K
124.59%
-298.04K
268.57%
-1.34M
347.98%
accounts payables
715.51K
-
642K
10.27%
-1.69M
363.25%
-175.90K
89.59%
-55.82K
68.27%
529.27K
1,048.17%
-452.78K
185.55%
other working capital
346.91K
-
1.10M
217.08%
311.69K
71.66%
5.89M
1,788.43%
-6.75M
214.67%
2.42M
135.90%
-2.77M
214.29%
-14.68M
430.09%
other non cash items
-236.37K
-
-584K
147.07%
-149.29K
74.44%
-343.91K
130.37%
-361.37K
5.08%
1.03M
384.96%
2.01M
95.68%
50.08M
2,385.35%
net cash provided by operating activities
-9.83M
-
-17.45M
77.50%
-13.52M
22.49%
-6.30M
53.39%
-21.71M
244.43%
-12.84M
40.87%
-22.02M
71.54%
investments in property plant and equipment
-458.68K
-
-116K
74.71%
-45.94K
60.40%
-61.38K
33.63%
-593.57K
867.00%
-265.19K
55.32%
-337.97K
27.45%
acquisitions net
-468.80K
-
purchases of investments
-12.20M
-
-11.09M
9.09%
-5.57M
-
-138.44K
97.51%
-105.93M
76,414.98%
sales maturities of investments
18.62M
-
14.96M
19.69%
6.66M
55.49%
10.84M
-
other investing activites
109.63K
-
2.17K
98.02%
net cash used for investing activites
5.97M
-
3.75M
37.13%
6.61M
76.25%
-530.18K
108.02%
-6.16M
1,062.56%
-294.00K
95.23%
-95.42M
32,356.04%
debt repayment
-558K
-
-6.94M
1,144.05%
-1.97K
-
-817.20K
41,466.58%
common stock issued
11.40M
-
13.37M
17.28%
9.09M
31.99%
38.41M
322.41%
18.90K
99.95%
123.97M
655,918.98%
common stock repurchased
dividends paid
other financing activites
3.01M
-
4.17M
38.48%
3.37M
19.05%
-324.65K
109.62%
1.71M
626.24%
2.12K
99.88%
-3.83M
180,675.94%
net cash used provided by financing activities
3.01M
-
15.01M
398.63%
9.80M
34.70%
8.77M
10.55%
40.12M
357.53%
19.05K
99.95%
119.33M
626,233.49%
effect of forex changes on cash
-89K
-
12.66K
114.22%
-14.25K
212.59%
145.76K
1,122.98%
-1.77K
101.21%
3.75K
312.09%
net change in cash
-852.69K
-
1.23M
243.78%
2.90M
136.76%
1.92M
33.84%
12.39M
545.12%
-13.11M
205.86%
1.89M
114.43%
cash at beginning of period
4.57M
-
3.71M
18.68%
4.94M
33.01%
7.84M
58.76%
9.77M
24.52%
22.15M
126.87%
9.04M
59.20%
10.93M
20.93%
cash at end of period
3.71M
-
4.94M
33.00%
7.84M
58.76%
9.76M
24.49%
22.15M
126.92%
9.04M
59.20%
10.93M
20.93%
10.93M
0%
operating cash flow
-9.83M
-
-17.45M
77.50%
-13.52M
22.49%
-6.30M
53.39%
-21.71M
244.43%
-12.84M
40.87%
-22.02M
71.54%
capital expenditure
-458.68K
-
-116K
74.71%
-45.94K
60.40%
-61.38K
33.63%
-593.57K
867.00%
-265.19K
55.32%
-337.97K
27.45%
free cash flow
-10.29M
-
-17.56M
70.71%
-13.57M
22.74%
-6.37M
53.09%
-22.31M
250.43%
-13.10M
41.26%
-22.36M
70.64%

All numbers in USD (except ratios and percentages)